ADHESION RECEPTOR ANTAGONISTS

摘要

Compounds of the formula I <IMG> ¦, and the corresponding 5,6,7,8-tetrahydroimidazo¢1,2-a!-pyridine derivatives, their physiologically acceptable salts and/or solvates, inhibit the binding of fibrinogen to the corresponding receptor and can be used for the treatment of thromboses, osteoporosis, oncoses, stroke, myocardial infarct, inflammations, arteriosclerosis and osteolytic disorders.